Formulation, Characterization and in-vitro Evaluation of Famciclovir Loaded Solid Lipid Nanoparticles for Improved Oral Absorption

被引:1
作者
Rawat, Pavan Kumar [1 ]
Tyagi, Chandra Kishore [1 ]
Shah, Sunil Kumar [2 ]
Pandey, Arun Kumar [3 ]
机构
[1] Sri Satya Sai Univ Technol & Med Sci, Coll Pharm, Dept Pharmaceut, Sehore, Madhya Pradesh, India
[2] Satya Sai Pharm Coll, Indore, India
[3] Alkem Lab Ltd, Mumbai, Maharashtra, India
关键词
Famciclovir; solid lipid nanoparticles; bioavailability; release kinetics; PHYSICOCHEMICAL CHARACTERIZATION; DELIVERY; CARRIERS; EMULSIFIERS; PENCICLOVIR; LOVASTATIN;
D O I
10.9734/JPRI/2020/v32i2930879
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Famciclovir loaded Solid Lipid Nanoparticles (SLNs) using triglycerides as solid lipids were successfully prepared using the double emulsion-solvent evaporation technique. Formulation parameters like amount and type of lipid and level of surfactants affected the nanoparticle characters. It was observed that nanoparticle characters like average particle size and distribution, drug content, entrapment efficiency and release pattern were dependent on these formulation variables. The optimized formulations depicted the desired characters of low particle size, in the range of 140-170 nm in case of Glyceryl monostearate (GMS) and glyceryl distearate (GDS) SLNs and 250-340 nm in case of glyceryl behenate (GB) SLNs and entrapment efficiencies in the range of 35-48%. In vitro drug release was extended upto 8 h and the release profile was explained by the Baker-Lonsdale model for spherical particles. Morphological examination by Scanning Electron Microscope (SEM) and Transmission Electron Microscope (TEM) displayed homogenous solid, spherical and non- porous particles. The formulations depicted good redispersibility after lyophilization and presence of residual solvents in the formulations within the prescribed limits suggested suitability of the preparation technique. Freeze- dried formulations were found to be stable in terms of particle size and drug loading even after 6 months of storage at refrigerated conditions.
引用
收藏
页码:1 / 17
页数:17
相关论文
共 35 条
[1]  
Abbasalipourkabir R, 2012, Pak J Biol Sci, V15, P141
[2]   Lipid nanocapsules for dermal application: A comparative study of lipid-based versus polymer-based nanocarriers [J].
Abdel-Mottaleb, Mona M. A. ;
Neumann, Dirk ;
Lamprecht, Alf .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 79 (01) :36-42
[3]  
Al-Qushawi A, 2016, IRAN J PHARM RES, V15, P663
[4]   Formulation and evaluation of nano lipid formulation containing CNS acting drug: molecular docking, in-vitro assessment and bioactivity detail in rats [J].
Alam, Mahtab ;
Najmi, Abul Kalam ;
Ahmad, Iqbal ;
Ahmad, Farhan Jalees ;
Akhtar, Md Jawaid ;
Imam, Syed Sarim ;
Akhtar, Mohd .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 :46-57
[5]   Solid Lipid Nanoparticles: A Potential Multifunctional Approach towards Rheumatoid Arthritis Theranostics [J].
Albuquerque, Joao ;
Moura, Catarina Costa ;
Sarmento, Bruno ;
Reis, Salette .
MOLECULES, 2015, 20 (06) :11103-11118
[6]   Rapid Microwave-Assisted Cisplatin-Loaded Solid Lipid Nanoparticles: Synthesis, Characterization and Anticancer Study [J].
Aldawsari, Hibah M. ;
Singh, Sima .
NANOMATERIALS, 2020, 10 (03)
[7]  
Algul D, 2018, J COSMET SCI, V69, P165
[8]   Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer [J].
Alp, Gokce ;
Aydogan, Nihal .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 149 :45-57
[9]   Chemical and structural investigation of lipid nanoparticles: drug-lipid interaction and molecular distribution [J].
Anantachaisilp, Suranan ;
Smith, Siwaporn Meejoo ;
Treetong, Alongkot ;
Pratontep, Sirapat ;
Puttipipatkhachorn, Satit ;
Ruktanonchai, Uracha Rungsardthong .
NANOTECHNOLOGY, 2010, 21 (12)
[10]  
Andalib Sare, 2012, Adv Biomed Res, V1, P45, DOI 10.4103/2277-9175.100147